New Jersey Medical School Clinical Research Center is the only site in the state participating in a worldwide effort to enroll 3,800 HIV negative individuals in the first Phase 3 HIV vaccine efficacy trial conducted in more than a decade. To read the full article.
Recent Posts
- He made his brothers get their arteries checked. Each had advanced heart disease.
- Yibin Kang’s team identifies new path to potential cancer treatments.
- Why a Life-Threatening Sedative Is Being Prescribed More Often for Seniors.
- NJACTS Community Engagement Core Available Services
- Join NJ ACTS for a Seminar on Clinical Research Record Retention on 3/2 at 12
Categories
- Community (2,444)
- Covid (997)
- CTO Events (6)
- News (3,097)
- Pilots (21)